SHOT:NSD-Safety Shot Inc (USD)

COMMON STOCK | Beverages - Non-Alcoholic |

Last Closing

USD 1.41

Change

+0.02 (+1.44)%

Market Cap

N/A

Volume

0.70M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-17 )

Largest Industry Peers for Beverages - Non-Alcoholic

Symbol Name Price(Change) Market Cap
KDP Keurig Dr Pepper Inc

N/A

USD 51.00B
MNST Monster Beverage Corp

+1.28 (+2.51%)

USD 49.79B
CCEP Coca-Cola European Partners PL..

-0.24 (-0.30%)

USD 37.54B
COKE Coca-Cola Consolidated Inc.

+4.26 (+0.34%)

USD 11.36B
CELH Celsius Holdings Inc

-0.52 (-1.49%)

USD 7.85B
FIZZ National Beverage Corp

+0.62 (+1.36%)

USD 4.16B
COCO Vita Coco Company Inc

+0.70 (+2.52%)

USD 1.56B
STKL SunOpta Inc.

-0.05 (-0.74%)

USD 0.78B
BRFH Barfresh Food Group Inc

-0.13 (-4.26%)

N/A
PEP PepsiCo Inc

-1.66 (-0.94%)

N/A

ETFs Containing SHOT

N/A

Market Performance

  Market Performance vs. Industry/Classification (Beverages - Non-Alcoholic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -59.83% 17% F 12% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -59.83% 17% F 12% F
Trailing 12 Months  
Capital Gain 1.44% 42% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.44% 25% F 45% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike